Dr. Claire Harrison, chief investigator of several JAK inhibitor trials, explains the COMFORT 1 and COMFORT 2 trails and how the results are showing evidence of extending survival for patients with a myeloproliferative condition.
- Alternative Medicine Bone and Joint Disorders Cancer Children's Health Chronic Pain
- Clinical Trials Digestive Disorders Endocrine Issues Genetic Disorders Geriatric Care Healthcare Issues Heart Problems
- Infectious disease Medical Breakthroughs Men's Health Mental Health Neurological Conditions Nutrition
- Oral Health Reproductive Health Respiratory Conditions Skin Conditions Surgery
- Vision and Hearing Women's Health
Patient Power connects you with the latest news and authoritative experts - patients and well as doctors - for your health concern.
Effective Therapies for Myeloma Patients After Disease Relapse
Watch the Video >>
Coming Soon:
How Epigenetic Testing Will Improve MPN Treatment
Dr. Srdan Verstovsek
Can We Afford New Maintenance Medicines for CLL
Dr. Peter Hillmen
Got Cancer, Keep a Journal
Contributor Christopher Springmann
There are currently no upcoming programs scheduled.
Featured Partner
National Comprehensive Cancer Network (NCCN)
National Comprehensive Cancer Network (NCCN)
Home :
Search :
Health Topics :
Program Guide :
Medical Experts :
News :
Community
About : Contact : Editorial Independence : Privacy Policy : Terms of Use
©2005 - 2013 Patient Power, LLC : Site by SiteWeld
About : Contact : Editorial Independence : Privacy Policy : Terms of Use
©2005 - 2013 Patient Power, LLC : Site by SiteWeld
 | We comply with the HONcode standard for trustworthy health information: verify here. Last Updated: 02/08/2013 |
